Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Cash And Cash Equivalents : HK$653.7 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Shanghai MicroPort MedBot (Group) Co Cash And Cash Equivalents?

Shanghai MicroPort MedBot (Group) Co's quarterly cash and cash equivalents declined from Dec. 2023 (HK$555.32 Mil) to Jun. 2024 (HK$237.97 Mil) but then increased from Jun. 2024 (HK$237.97 Mil) to Dec. 2024 (HK$653.66 Mil).

Shanghai MicroPort MedBot (Group) Co's annual cash and cash equivalents declined from Dec. 2022 (HK$835.26 Mil) to Dec. 2023 (HK$555.32 Mil) but then increased from Dec. 2023 (HK$555.32 Mil) to Dec. 2024 (HK$653.66 Mil).

Shanghai MicroPort MedBot (Group) Co Cash And Cash Equivalents Historical Data

The historical data trend for Shanghai MicroPort MedBot (Group) Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai MicroPort MedBot (Group) Co Cash And Cash Equivalents Chart

Shanghai MicroPort MedBot (Group) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash And Cash Equivalents

Get a 7-Day Free Trial

1,774.98

2,376.48

835.26

555.32

653.66

Shanghai MicroPort MedBot (Group) Co Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash And Cash Equivalents	Get a 7-Day Free Trial						835.26	770.68	555.32	237.97	653.66

Shanghai MicroPort MedBot (Group) Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Shanghai MicroPort MedBot (Group) Co (HKSE:02252) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Shanghai MicroPort MedBot (Group) Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Shanghai MicroPort MedBot (Group) Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai MicroPort MedBot (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai MicroPort MedBot (Group) Co Ltd (HKSE:02252) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1601 Zhangdong Road, Room 101, Area B, Building 1, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN

Website

https://www.medbotsurgical.com

Shanghai MicroPort MedBot (Group) Co Ltd is a surgical robot company dedicated to designing, developing, and commercializing surgical robots to assist surgeons in performing complex surgical procedures. Its business covers various surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures, and has accumulated several products at various stages as those in development, clinical trials, registration, and commercialisation. The company derives revenue principally from the sales of surgical robot systems, instruments, and accessories, and the provision of services through appointed distributors. Geographically, it derives key revenue from the People's Republic of China, followed by Europe, Africa, Australia, and other regions.

Executives

He Chao	2201 Interest of corporation controlled by you
Ji Shufang	2202 Interest of your spouse
Shang Hai Qing Zhen Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo	2103 Interests held jointly with another person
Wei Chuang Yi Liao Ke Xue You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Qing Min Qi Ye Guan Li Zi Xun Zhong Xin You Xian He Huo	2101 Beneficial owner
Wei Chuang Tou Zi Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Yuan Shuai	2201 Interest of corporation controlled by you
Wu Kaili	2202 Interest of your spouse
Shenzhen Gao Ling Tiancheng Phase Iii Investment Co., Ltd.	2201 Interest of corporation controlled by you
Shenzhen Gao Ling Muqi Equity Investment Fund Llp	2201 Interest of corporation controlled by you
Xiamen Gao Ling Ruiqi Equity Investment Fund Llp	2201 Interest of corporation controlled by you
Zhuhai Gao Ling Chongheng Equity Investment Llp	2101 Beneficial owner
Shang Hai Wei Chuang Tou Zi Kong Gu You Xian Gong Si	2201 Interest of corporation controlled by you
Shang Hai Mo Hua Ren Gong Zhi Neng Ke Ji You Xian Gong Si	2103 Interests held jointly with another person

Shanghai MicroPort MedBot (Group) Co Headlines

No Headlines